SPOTLIGHT -
August 15th 2024
To safeguard patient access to life-saving medications, pharma companies must prioritize building robust resilience strategies that encompass IT systems, inventory management, risk mitigation, and regulatory compliance.
August 9th 2023
Report on lessons from crisis includes—and ignites—some criticism.
January 30th 2023
Agency panel backs the use of a common bivalent shot for all patients.
May 1st 2020
The key industry areas that will experience downstream pressures in the wake of the coronavirus pandemic.
Drug Pricing Back in the Spotlight
Should therapies and vaccines be cheap or free in a pandemic and would that really dry up innovation?
Strategic Realignment for a Better Future
In adjusting to the long-term aftershocks from the coronavirus pandemic, pharma companies will need to focus on change in three core areas.